These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38303229)

  • 1. [Considering Recurrence Prevention Regimen for Colorectal Cancer Patients with Hyperammonemia Caused by Chemotherapy Containing 5-Fluorouracil].
    Aomatsu N; Tsujio G; Aomatsu K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1851-1853. PubMed ID: 38303229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Hyperammonemic Encephalopathy following mFOLFOX6 plus Panitumumab Therapy for Rectal Cancer].
    Tsujio G; Muguruma K; Eguchi S; Iseki Y; Miki Y; Yoshii M; Fukuoka T; Tamura T; Shibutani M; Nagahara H; Toyokawa T; Tanaka H; Lee S; Yashiro M; Ohira M
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):2073-2075. PubMed ID: 35045497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case Altered Consciousness Due to 5-Fluorouracil-Induced Hyperammonemia in a Patient with Recurrent Colorectal Cancer].
    Sawazaki S; Numata M; Ju M; Morita J; Komori K; Maezawa Y; Amano S; Aoyama T; Tamagawa H; Sato T; Oshima T; Mushiake H; Yukawa N; Masuda M; Rino Y
    Gan To Kagaku Ryoho; 2019 Oct; 46(10):1632-1634. PubMed ID: 31631158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Disturbance of Consciousness Due to Hyperammonemia during Chemotherapy for Metastasis of Sigmoid Colon Cancer].
    Kaizaki R; Inoue T; Eguchi S; Nishiyama T; Nobori C; Kunimoto T; Okazaki Y; Takatsuka S; Tsukamoto T; Nishiguchi Y
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1777-1779. PubMed ID: 33468826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperammonemia with impaired consciousness caused by continuous 5-fluorouracil infusion for colorectal cancer: A case report.
    Nakamura T; Shibata S; Miyatani Y; Matsubara H
    Int J Clin Pharmacol Ther; 2020 Dec; 58(12):727-731. PubMed ID: 32909537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group.
    Bond MJG; Bolhuis K; Loosveld OJL; de Groot JWB; Droogendijk H; Helgason HH; Hendriks MP; Klaase JM; Kazemier G; Liem MSL; Rijken AM; Verhoef C; de Wilt JHW; de Jong KP; Gerhards MF; van Amerongen MJ; Engelbrecht MRW; van Lienden KP; Molenaar IQ; de Valk B; Haberkorn BCM; Kerver ED; Erdkamp F; van Alphen RJ; Mathijssen-van Stein D; Komurcu A; Lopez-Yurda M; Swijnenburg RJ; Punt CJA;
    Lancet Oncol; 2023 Jul; 24(7):757-771. PubMed ID: 37329889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia.
    Nishikawa Y; Funakoshi T; Horimatsu T; Miyamoto S; Matsubara T; Yanagita M; Nakagawa S; Yonezawa A; Matsubara K; Muto M
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):629-633. PubMed ID: 28204913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Consciousness Disturbance Caused by Hyperammonemia during a mFOLFOX6 Regimen for Metastatic Colon Cancer].
    Kagawa Y; Kato T; Naito A; Murakami K; Katsura Y; Ohmura Y; Okishiro M; Takeno A; Egawa C; Takeda Y; Tamura S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2160-2. PubMed ID: 26805297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A Case of Recurrent Hyperammonemic Encephalopathy during Adjuvant Chemotherapy(Modified FOLFOX6)for Colorectal Cancer].
    Yoshino Y; Tamura A; Kagami S; Funahashi K
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1665-1668. PubMed ID: 30449860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Case of Hyperammonemia Induced by High-Dose Fluorouracil].
    Hagiwara A; Abe M; Mafune K; Saito M; Kusakabe A
    Gan To Kagaku Ryoho; 2019 May; 46(Suppl 1):147-149. PubMed ID: 31189842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of 5-fluorouracil-induced hyperammmonia after chemotherapy for metastatic colon cancer].
    Nakamura M; Kobashikawa K; Tamura J; Takaki R; Ohshiro M; Matayoshi R; Hirata T; Kinjyo F; Fujita J
    Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1744-50. PubMed ID: 19966516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of hyperammonemic encephalopathy related to 5-FU in an aged patient with recurrent colon cancer treated with FOLFIRI therapy].
    Okamura T; Kawachi Y; Nikkuni K; Nishimura A; Makino S; Kawahara M; Kitami C; Hashimoto Y
    Gan To Kagaku Ryoho; 2013 May; 40(5):671-3. PubMed ID: 23863598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hyperammonemia with encephalopathy related to FOLFIRI chemotherapy for advanced colon cancer].
    Toyokawa A; Nakajima T; Inui K; Yamashita H; Gon H; Kanemitsu K; Tanaka K; Tsukamoto T; Hamabe Y; Ishida T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1167-9. PubMed ID: 19620810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Consciousness Disorder Due to Hyperammonemia Induced by Modified FOLFOX6 for Multiple Liver Metastasis from Rectal Cancer].
    Furukawa S; Hiraki M; Sakurai R; Kohya N; Murayama K; Kamachi K; Iwasaki M; Samejima R
    Gan To Kagaku Ryoho; 2024 May; 51(5):567-570. PubMed ID: 38881070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
    Cremolini C; Antoniotti C; Rossini D; Lonardi S; Loupakis F; Pietrantonio F; Bordonaro R; Latiano TP; Tamburini E; Santini D; Passardi A; Marmorino F; Grande R; Aprile G; Zaniboni A; Murgioni S; Granetto C; Buonadonna A; Moretto R; Corallo S; Cordio S; Antonuzzo L; Tomasello G; Masi G; Ronzoni M; Di Donato S; Carlomagno C; Clavarezza M; Ritorto G; Mambrini A; Roselli M; Cupini S; Mammoliti S; Fenocchio E; Corgna E; Zagonel V; Fontanini G; Ugolini C; Boni L; Falcone A;
    Lancet Oncol; 2020 Apr; 21(4):497-507. PubMed ID: 32164906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)-Study Design and Rationale.
    Nagata N; Mishima H; Kurosawa S; Oba K; Sakamoto J
    Clin Colorectal Cancer; 2017 Jun; 16(2):154-157.e1. PubMed ID: 28284575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperammonemia with Disturbance of Consciousness during 5-FU plus Nedaplatin Therapy for Esophageal Cancer-A Case Report].
    Okada T; Hirakawa T; Morimoto J; Tanaka H; Miyamoto H; Tsujio G; Kurihara S; Matsutani S; Nagashima D; Hirata K; Iwauchi T; Yamagata S; Uchima Y; Takeuchi K
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):1839-1841. PubMed ID: 33468846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
    Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
    Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in
    Modest DP; Karthaus M; Fruehauf S; Graeven U; Müller L; König AO; Fischer von Weikersthal L; Caca K; Kretzschmar A; Goekkurt E; Haas S; Kurreck A; Stahler A; Held S; Jarosch A; Horst D; Reinacher-Schick A; Kasper S; Heinemann V; Stintzing S; Trarbach T
    J Clin Oncol; 2022 Jan; 40(1):72-82. PubMed ID: 34533973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Severe Hyperammonemic Encephalopathy in a Dialysis Patient Following mFOLFOX6 Therapy].
    Furuyama T; Enjoji M; Yamato M; Kondo I; Hinokida M; Tatsutomi Y; Nakazawa K; Nagayama K; Ushirokoji Y
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1676-1678. PubMed ID: 35046294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.